BUY Mankind Pharma Limited — Rajesh Satpute
byRajesh SatputeHorizon: NA (inferred Intraday)5 Nov 2026, 9:09 am ISTvia CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · adjacent horizon·26 Oct · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Mankind Pharma
- BUY — J.P. Morgan27 Oct 2026 · ~1 year · target ₹2,700 · Active
- BUY — Nirmal Bang Securities27 Oct 2026 · ~1 year · target ₹2,995 · Active
- BUY — Vaishali Parekh, Prabhudas Lilladher27 Oct 2026 · Same day · target ₹2,500 · Expired
- BUY — Rakesh Bansal27 Oct 2026 · Same day · target ₹2,520 · Target hit
- BUY — Kotak Securities27 Oct 2026 · ~1 year · target ₹3,035 · Active
More from Rajesh Satpute
- BUY Zensar Technologies6 Nov 2026 · ~2 weeks · target ₹610 · Active
- BUY Karur Vysya Bank6 Nov 2026 · Same day · target ₹370 · Target hit
- BUY SBI Life Insurance Company5 Nov 2026 · Same day · target ₹1,760 · Expired
- BUY One 97 Communications5 Nov 2026 · ~2 weeks · target ₹1,850 · Active
- BUY Hindalco Industries4 Nov 2026 · ~2 weeks · target ₹980 · SL hit

